Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Tomohiro, Omura"'
Autor:
Takeshi Tomida, Takeshi Kimura, Kazuhiro Yamamoto, Atsushi Uda, Yuki Matsumoto, Naoki Tamura, Masashi Iida, Akiko Tanifuji, Kumiko Matsumoto, Naomi Mizuta, Kei Ebisawa, Goh Ohji, Tomohiro Omura, Kentaro Iwata, Ikuko Yano
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract Purpose While nirmatrelvir/ritonavir (NMV-r) has been positioned as a first-line treatment for mild to moderate COVID-19, it has multiple and significant drug-drug interactions (DDIs). The use of NMV-r in Japan has been limited compared to t
Externí odkaz:
https://doaj.org/article/96e1fb92be494ee0a05d38ad27641599
Autor:
Tomoko Kurimura, Kazuhiro Yamamoto, Hidekazu Tanaka, Takayoshi Toba, Takeshi Kimura, Yasushi Habu, Kotaro Itohara, Yumi Kitahiro, Tomohiro Omura, Ikuko Yano
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract Background Optimised antithrombotic therapy requires clinical experience and an understanding of the current guidelines. This retrospective study aimed to evaluate whether pharmacist interviews and interventions with patients taking oral ant
Externí odkaz:
https://doaj.org/article/a55cde225b864c589cdc8b48689766c2
Autor:
Yumi Kitahiro, Kazuhiro Yamamoto, Kimikazu Yakushijin, Takeshi Ioroi, Masaaki Tanda, Kotaro Itohara, Tomohiro Omura, Hironobu Minami, Ikuko Yano
Publikováno v:
JMIR Research Protocols, Vol 13, p e54882 (2024)
BackgroundRituximab, an anti-CD20 monoclonal antibody, can cause infusion reactions (IRs), especially during the initial rituximab infusion therapy. Generally, patients are administered a histamine H1-receptor antagonist before the rituximab infusion
Externí odkaz:
https://doaj.org/article/62cc9513b15e488294dbb9bbb690dca0
Autor:
Walaa Y. B. Mahdy, Kazuhiro Yamamoto, Takahiro Ito, Naoko Fujiwara, Kazumichi Fujioka, Tadasu Horai, Ikuo Otsuka, Hitomi Imafuku, Tomohiro Omura, Kazumoto Iijima, Ikuko Yano
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 4, Pp 618-630 (2023)
Abstract This study aimed to determine the effects of pregnancy and ontogeny on risperidone and paliperidone pharmacokinetics by assessing their serum concentrations in two subjects and constructing a customized physiologically‐based pharmacokineti
Externí odkaz:
https://doaj.org/article/c5280c34f5e34e028f4b651651172d55
Autor:
Takeshi Kimura, Misa Fujita, Michiko Shimizu, Kasumi Sumiyoshi, Saho Bansho, Kazuhiro Yamamoto, Tomohiro Omura, Ikuko Yano
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract Background Potentially inappropriate medications (PIMs) and polypharmacy in older adults lead to increase the risk of adverse drug events. This study aimed to evaluate the effectiveness of pharmacist intervention combining the criteria for d
Externí odkaz:
https://doaj.org/article/bb12bfce609447d493092b90404cf107
Autor:
Toru Konishi, Yumi Kitahiro, Naoko Fujiwara, Kazuhiro Yamamoto, Mari Hashimoto, Takahiro Ito, Kotaro Itohara, Kazumichi Fujioka, Hitomi Imafuku, Ikuo Otsuka, Tomohiro Omura, Ikuko Yano
Publikováno v:
Therapeutic Drug Monitoring; Oct2024, Vol. 46 Issue 5, p687-691, 5p
Autor:
Takashi Ogihara, Takayuki Nakagawa, Maho Hayashi, Madoka Koyanagi, Atsushi Yonezawa, Tomohiro Omura, Shunsaku Nakagawa, Noriaki Kitada, Satoshi Imai, Kazuo Matsubara
Publikováno v:
Journal of Pharmacological Sciences, Vol 141, Iss 4, Pp 131-138 (2019)
Oxaliplatin, a platinum-based chemotherapeutic drug, frequently induces peripheral neuropathy. Accumulating evidences suggest a possible relationship between peripheral vascular impairment and peripheral neuropathy. In this study, we investigated the
Externí odkaz:
https://doaj.org/article/4463345bb3574ba6bf7fb5bfda88c3e4
Autor:
Tomohiro Omura, Luna Nomura, Ran Watanabe, Hiroki Nishiguchi, Kazuhiro Yamamoto, Satoshi Imai, Shunsaku Nakagawa, Kotaro Itohara, Atsushi Yonezawa, Takayuki Nakagawa, Junichi Kunimasa, Ikuko Yano, Kazuo Matsubara
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 14 (2021)
Endoplasmic reticulum (ER) stress has been reported as a cause of Parkinson’s disease (PD). We have previously reported that the ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) and its stabilizing factor suppressor/enhancer lin-12-like (SEL
Externí odkaz:
https://doaj.org/article/bfc401519802464781c4bc5d94b4de8a
Publikováno v:
Biological and Pharmaceutical Bulletin. 46:788-795
Autor:
MASAAKI TANDA, KAZUHIRO YAMAMOTO, TOMOKI HORI, HIROKI NISHIGUCHI, MIKI YAGI, MICHIKO SHIMIZU, TORU KONISHI, TOMONORI OZAKI, NATSUE YOSHIOKA, MOTOKO TACHIHARA, TAKEFUMI ITO, SHIGEKI IKUSHIMA, TOMOHIRO OMURA, IKUKO YANO
Publikováno v:
Anticancer Research. 43:1775-1783